Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SanBio is a leading Japanese biotechnology company specializing in the development of regenerative medicine. Through innovative cell therapies, SanBio researches new treatment methods for neurological disorders to sustainably improve the quality of life for patients around the world.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SanBio is scheduled to report its next quarterly earnings on 12/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
SanBio last reported quarterly earnings on 9/14/2026 (Q2 2026). Earnings per share (EPS) came in at -12.24 JPY.
Across its last 3 earnings reports, SanBio stock moved by ±1.6% on average the following day. The largest reaction was +2.8% on 09/14/2026; 2 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.